900
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy

, , ORCID Icon, , , , , & show all
Pages 899-915 | Received 26 Oct 2022, Accepted 01 Feb 2023, Published online: 18 Feb 2023

References

  • Ni X, Lai Y. Keratinocyte: a trigger or an executor of psoriasis? J Leukoc Biol. 2020;108(2):485–491. doi:10.1002/jlb.5mr0120-439r
  • Lin X, Huang T. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50(6):585–595. doi:10.3109/10715762.2016.1162301
  • Baek J, Lee MG. Oxidative stress and antioxidant strategies in dermatology. Redox Rep. 2016;21(4):164–169. doi:10.1179/1351000215y.0000000015
  • Miodovnik M, Koren R, Ziv E, Ravid A. The inflammatory response of keratinocytes and its modulation by vitamin D: the role of MAPK signaling pathways. J Cell Physiol. 2012;227(5):2175–2183. doi:10.1002/jcp.22951
  • Bito T, Nishigori C. Impact of reactive oxygen species on keratinocyte signaling pathways. J Dermatol Sci. 2012;68(1):3–8. doi:10.1016/j.jdermsci.2012.06.006
  • Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264–272. doi:10.1111/1346-8138.14139
  • López-Cano M, Filgaira I, Nolen EG, et al. Optical control of adenosine A(3) receptor function in psoriasis. Pharmacol Res. 2021;170:105731. doi:10.1016/j.phrs.2021.105731
  • Merighi S, Borea PA, Varani K, Gessi S. Deregulation of Adenosine Receptors in Psoriatic Epidermis: an Option for Therapeutic Treatment. J Invest Dermatol. 2017;137(1):11–13. doi:10.1016/j.jid.2016.08.001
  • Ciruela F, Jacobson KA. Optical Control of Adenosine A(3) Receptor Signaling: towards a Multimodal Phototherapy in Psoriasis? Front Immunol. 2022;13:904762. doi:10.3389/fimmu.2022.904762
  • Nedelcu RI, Balaban M, Turcu G, et al. Efficacy of methotrexate as anti-inflammatory and anti-proliferative drug in dermatology: three case reports. Exp Ther Med. 2019;18(2):905–910. doi:10.3892/etm.2019.7511
  • Coates LC, Merola JF, Grieb SM, Mease PJ, Callis Duffin K. Methotrexate in Psoriasis and Psoriatic Arthritis. J Rheumatol Suppl. 2020;96:31–35. doi:10.3899/jrheum.200124
  • Ekman AK, Bivik Eding C, Rundquist I, Enerbäck C. IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis. J Invest Dermatol. 2019;139(7):1564–1573.e8. doi:10.1016/j.jid.2019.01.014
  • Lugović-Mihić L, Novak-Bilić G, Vučić M, Japundžić I, Bukvić I. CD44 expression in human skin: high expression in irritant and allergic contact dermatitis and moderate expression in psoriasis lesions in comparison with healthy controls. Contact Dermatitis. 2020;82(5):297–306. doi:10.1111/cod.13463
  • Darwish NF, Tabra SAA, Baiomy NN, Mahmoud HA, Mariah RA, Hablas SA. The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients. Egyptian Rheumatology Rehabilitation. 2022;49(1):5. doi:10.1186/s43166-021-00107-9
  • Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov. 2009;3(1):40–48. doi:10.2174/187221309787158399
  • Hua Y, Chang T, Jiang K, et al. ROS-sensitive calcipotriol nano-micelles prepared by methoxypolyethylene glycol (mPEG) - modified polymer for the treatment of psoriasis. Drug Deliv. 2022;29(1):1903–1913. doi:10.1080/10717544.2022.2086944
  • Hu J, Bian Q, Ma X, Xu Y, Gao J. A double-edged sword: ROS related therapies in the treatment of psoriasis. Asian J Pharm Sci. 2022;17(6):798–816. doi:10.1016/j.ajps.2022.10.005
  • Aickara D, Bashyam AM, Pichardo RO, Feldman SR. Topical methotrexate in dermatology: a review of the literature. J Dermatolog Treat. 2022;33(1):512–517. doi:10.1080/09546634.2020.1770170
  • Li N, Qin Y, Dai D, et al. Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis. Front Bioeng Biotechnol. 2021;9:804415. doi:10.3389/fbioe.2021.804415
  • Roberson ED, Bowcock AM. Psoriasis genetics: breaking the barrier. Trends Genet. 2010;26(9):415–423. doi:10.1016/j.tig.2010.06.006
  • Li J, Ghatak S, El Masry MS, et al. Topical Lyophilized Targeted Lipid Nanoparticles in the Restoration of Skin Barrier Function following Burn Wound. Mol Ther. 2018;26(9):2178–2188. doi:10.1016/j.ymthe.2018.04.021
  • Zhao Y, Zhou Y, Yang D, et al. Intelligent and spatiotemporal drug release based on multifunctional nanoparticle-integrated dissolving microneedle system for synergetic chemo-photothermal therapy to eradicate melanoma. Acta Biomater. 2021;135:164–178. doi:10.1016/j.actbio.2021.09.009
  • Bhadale RS, Londhe VY. A systematic review of carbohydrate-based microneedles: current status and future prospects. J Mater Sci Mater Med. 2021;32(8):89. doi:10.1007/s10856-021-06559-x
  • Bigliardi PL. Role of Skin pH in Psoriasis. Curr Probl Dermatol. 2018;54:108–114. doi:10.1159/000489524
  • Xin X, Kumar V, Lin F, et al. Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy. Sci Adv. 2020;6(46):548. doi:10.1126/sciadv.abd6764
  • Li H, Hu D, Liang F, Huang X, Zhu Q. Influence factors on the critical micelle concentration determination using pyrene as a probe and a simple method of preparing samples. R Soc Open Sci. 2020;7(3):192092. doi:10.1098/rsos.192092
  • Xin X, Zhou Y, Li J, Zhang K, Qin C, Yin L. CXCL10-coronated thermosensitive “stealth” liposomes for sequential chemoimmunotherapy in melanoma. Nanomedicine. 2022;48:102634. doi:10.1016/j.nano.2022.102634
  • Lv Y, Xu C, Zhao X, et al. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells. ACS Nano. 2018;12(2):1519–1536. doi:10.1021/acsnano.7b08051
  • Rinaldi A, Caraffi R, Grazioli MV, et al. Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines. Polymers. 2022;14(4):548. doi:10.3390/polym14040687
  • Li J, Ding Z, Li Y, et al. Reactive oxygen species-sensitive thioketal-linked mesoporous silica nanoparticles as drug carrier for effective antibacterial activity. Mater Des. 2020;195:109021. doi:10.1016/j.matdes.2020.109021
  • Shim MS, Xia Y. A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells. Angew Chem Int Ed Engl. 2013;52(27):6926–6929. doi:10.1002/anie.201209633
  • Saha I, Rai VK. Hyaluronic acid based microneedle array: recent applications in drug delivery and cosmetology. Carbohydr Polym. 2021;267:118168. doi:10.1016/j.carbpol.2021.118168
  • Makvandi P, Kirkby M, Hutton ARJ, et al. Engineering Microneedle Patches for Improved Penetration: analysis, Skin Models and Factors Affecting Needle Insertion. Nanomicro Lett. 2021;13(1):93. doi:10.1007/s40820-021-00611-9
  • Yan G, Warner KS, Zhang J, Sharma S, Gale BK. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm. 2010;391(1–2):7–12. doi:10.1016/j.ijpharm.2010.02.007
  • Wang M, Han Y, Yu X, et al. Upconversion Nanoparticle Powered Microneedle Patches for Transdermal Delivery of siRNA. Adv Healthc Mater. 2020;9(2):e1900635. doi:10.1002/adhm.201900635
  • Thatikonda S, Pooladanda V, Sigalapalli DK, Godugu C. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Cell Death Dis. 2020;11(1):21. doi:10.1038/s41419-019-2212-y
  • Zhang J, Yang X, Qiu H, Chen W. Weight loss may be unrelated to dietary intake in the imiquimod-induced plaque psoriasis mice model. Open Life Sci. 2020;15(1):79–82. doi:10.1515/biol-2020-0009